Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| MYRIAD GENETICS INC | 92,329 | reported | 05 Jun 2025 | tx 8+138,341−46,012 |
| ALNYLAM PHARMACEUTICALS, INC. | 1,446 | reported | 20 May 2026 | tx 32+71,929−36,036 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 20 May 2026 | GRANT_AWARD | ALNYLAM PHARMACEUTICALS, INC. | 671 | 0.00 USD | |
| 20 May 2026 | GRANT_AWARD | ALNYLAM PHARMACEUTICALS, INC. | 1,441 | 0.00 USD | deriv |
| 09 Sept 2025 | EXERCISE | ALNYLAM PHARMACEUTICALS, INC. | 18,000 | 100.65 USD | |
| 09 Sept 2025 | SALE | ALNYLAM PHARMACEUTICALS, INC. | 1,183 | 477.47 USD | |
| 09 Sept 2025 | SALE | ALNYLAM PHARMACEUTICALS, INC. | 972 | 476.31 USD | |
| 09 Sept 2025 | SALE | ALNYLAM PHARMACEUTICALS, INC. | 1,645 | 457.44 USD | |
| 09 Sept 2025 | SALE | ALNYLAM PHARMACEUTICALS, INC. | 1,450 | 478.67 USD | |
| 09 Sept 2025 | SALE | ALNYLAM PHARMACEUTICALS, INC. | 1,386 | 479.55 USD | |
| 09 Sept 2025 | SALE | ALNYLAM PHARMACEUTICALS, INC. | 25 | 480.98 USD | anomaly |
| 09 Sept 2025 | SALE | ALNYLAM PHARMACEUTICALS, INC. | 1,888 | 458.86 USD | |
| 09 Sept 2025 | SALE | ALNYLAM PHARMACEUTICALS, INC. | 1,403 | 459.73 USD | |
| 09 Sept 2025 | SALE | ALNYLAM PHARMACEUTICALS, INC. | 473 | 460.71 USD | |
| 09 Sept 2025 | SALE | ALNYLAM PHARMACEUTICALS, INC. | 2,290 | 461.92 USD | |
| 09 Sept 2025 | SALE | ALNYLAM PHARMACEUTICALS, INC. | 1,652 | 463.00 USD | |
| 09 Sept 2025 | SALE | ALNYLAM PHARMACEUTICALS, INC. | 799 | 464.36 USD | |
| 09 Sept 2025 | SALE | ALNYLAM PHARMACEUTICALS, INC. | 222 | 471.25 USD | |
| 09 Sept 2025 | SALE | ALNYLAM PHARMACEUTICALS, INC. | 823 | 472.82 USD | |
| 09 Sept 2025 | SALE | ALNYLAM PHARMACEUTICALS, INC. | 838 | 474.22 USD | |
| 09 Sept 2025 | SALE | ALNYLAM PHARMACEUTICALS, INC. | 951 | 474.85 USD | |
| 09 Sept 2025 | EXERCISE | ALNYLAM PHARMACEUTICALS, INC. | 18,000 | 0.00 USD | deriv |
| 05 Jun 2025 | GRANT_AWARD | MYRIAD GENETICS INC | 49,796 | 0.00 USD | |
| 29 Aug 2024 | PURCHASE | ALNYLAM PHARMACEUTICALS, INC. | 32 | 286.00 USD | |
| 17 Oct 2024 | PURCHASE | ALNYLAM PHARMACEUTICALS, INC. | 4 | 302.67 USD | |
| 16 Apr 2025 | SALE | ALNYLAM PHARMACEUTICALS, INC. | 36 | 232.86 USD | anomaly |
| 08 May 2025 | GRANT_AWARD | ALNYLAM PHARMACEUTICALS, INC. | 775 | 0.00 USD |